Add to ORKGUpdated June 1, 2020CDC wants to learn more about the percentage of people in select counties and communities in the United States who have been infected with SARS-CoV-2, the virus that causes COVID-19. Learning about infections in these communities can help CDC to understand more about how COVID-19 might be spreading in other communities with similar populations.Looking for Past Infections in the Community -- Systematic Sampling -- Impact of the Results -- Seroprevalence Survey (looking for COVID-19 antibodies using blood tests) in Georgia.2020774
seroprevalence-surveys-for-COVID-19.pdfOverview of Seroprevalence Surveys for COVID-19 / Myrna Charl...
Public health surveillance systems likely underestimate the true prevalence and incidence of SARS-Co...
Objectives To estimate the seroprevalence of anti-SARS-CoV-2 IgG and IgM among Massachusetts residen...
Updated Sept. 18, 2020CDC wants to learn more about the percentage of people in the United States wh...
CDC is partnering with commercial laboratories to conduct a large-scale geographic seroprevalence su...
CDC is working with state, local, territorial, academic, and commercial partners to better understan...
Updated July 10, 2020CDC is learning more about how people in special populations like healthcare wo...
What is already known about this topic? SARS-CoV-2 infection in persons who are asymptomatic or not ...
Updated Sept. 18, 2020CDC is partnering with commercial laboratories to conduct and publish results ...
CDC is conducting a nationwide COVID-19 seroprevalence survey in 25 U.S. metropolitan areas to under...
Transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is ongoing in...
Updated Nov. 3, 2020CDC has developed a laboratory test to help estimate how many people in the Unit...
CDC has developed a laboratory blood test to assist with efforts to determine how much of the U.S. p...
ABSTRACT Characterizing the asymptomatic spread of SARS-CoV-2 is important for understanding the COV...
INTRODUCTION: The COVID-19 Community Research Partnership is a population-based longitudinal syndrom...
seroprevalence-surveys-for-COVID-19.pdfOverview of Seroprevalence Surveys for COVID-19 / Myrna Charl...
Public health surveillance systems likely underestimate the true prevalence and incidence of SARS-Co...
Objectives To estimate the seroprevalence of anti-SARS-CoV-2 IgG and IgM among Massachusetts residen...
Updated Sept. 18, 2020CDC wants to learn more about the percentage of people in the United States wh...
CDC is partnering with commercial laboratories to conduct a large-scale geographic seroprevalence su...
CDC is working with state, local, territorial, academic, and commercial partners to better understan...
Updated July 10, 2020CDC is learning more about how people in special populations like healthcare wo...
What is already known about this topic? SARS-CoV-2 infection in persons who are asymptomatic or not ...
Updated Sept. 18, 2020CDC is partnering with commercial laboratories to conduct and publish results ...
CDC is conducting a nationwide COVID-19 seroprevalence survey in 25 U.S. metropolitan areas to under...
Transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is ongoing in...
Updated Nov. 3, 2020CDC has developed a laboratory test to help estimate how many people in the Unit...
CDC has developed a laboratory blood test to assist with efforts to determine how much of the U.S. p...
ABSTRACT Characterizing the asymptomatic spread of SARS-CoV-2 is important for understanding the COV...
INTRODUCTION: The COVID-19 Community Research Partnership is a population-based longitudinal syndrom...
seroprevalence-surveys-for-COVID-19.pdfOverview of Seroprevalence Surveys for COVID-19 / Myrna Charl...
Public health surveillance systems likely underestimate the true prevalence and incidence of SARS-Co...
Objectives To estimate the seroprevalence of anti-SARS-CoV-2 IgG and IgM among Massachusetts residen...